Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer

AW Caliri, S Tommasi, A Besaratinia - Mutation Research/Reviews in …, 2021 - Elsevier
Smoking is a major risk factor for a variety of diseases, including cancer and immune-
mediated inflammatory diseases. Tobacco smoke contains a mixture of chemicals, including …

From cultivation to cancer: formation of N-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications

SB Stanfill, SS Hecht, AC Joerger… - Critical Reviews in …, 2023 - Taylor & Francis
Tobacco use is a major cause of preventable morbidity and mortality globally. Tobacco
products, including smokeless tobacco (ST), generally contain tobacco-specific N …

A prime editor mouse to model a broad spectrum of somatic mutations in vivo

ZA Ely, N Mathey-Andrews, S Naranjo, SI Gould… - Nature …, 2024 - nature.com
Genetically engineered mouse models only capture a small fraction of the genetic lesions
that drive human cancer. Current CRISPR–Cas9 models can expand this fraction but are …

[HTML][HTML] Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas

RWC Wong, JHY Ng, KC Han, YP Leung, CM Shek… - Modern Pathology, 2021 - Elsevier
Recent changes in the classification of cervical adenocarcinomas have re-categorized
serous carcinoma as potentially nonexistent. However, clinical and pathological profiles of …

Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation

L Li, P Li, X Ma, S Zeng, Y Peng, G Zhang - Biochemical Pharmacology, 2022 - Elsevier
Abstract p53 inactivation by disabling its function is a hallmark in lung carcinomas,
emphasizing the significance of restoring p53 function as an attractive therapeutic strategy …

KRAS mutations are associated with shortened survival in patients with epithelioid malignant pleural mesothelioma

M Vannucchi, V Pennati, C Mencaroni, C Defraia… - Cancers, 2023 - mdpi.com
Simple Summary Malignant pleural mesothelioma (MPM) is an aggressive tumor with
implacable prognosis. It commonly harbors loss-of-function mutations in BAP1, NF2 …

p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications

DA Benitez, G Cumplido-Laso, M Olivera-Gómez… - Biomedicines, 2024 - mdpi.com
The TP53 gene is renowned as a tumor suppressor, playing a pivotal role in overseeing the
cell cycle, apoptosis, and maintaining genomic stability. Dysregulation of p53 often …

Identification of a Novel Oxidative Stress-and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer

H Zhao, Y Huang, G Tong, W Wu, Y Ren - International Journal of …, 2023 - mdpi.com
The objective of this study was to identify a kind of prognostic signature based on oxidative
stress-and anoikis-related genes (OARGs) for predicting the prognosis and immune …

Small-molecule MX-C2/3 suppresses non-small cell lung cancer progression via p53 activation

L Li, W Du, H Wang, Y Zhao, Z Huang, Y Peng… - Chemico-Biological …, 2022 - Elsevier
Abstract p53 inactivation is a common feature in non-small cell lung cancer (NSCLC)
resulting in NSCLC malignant transformation. Targeting serine 392 phosphorylation to …

Association of ESR1 Germline Variants with TP53 Somatic Variants in Breast Tumors in a Genome-wide Study

NP Tjader, AJ Beer, J Ramroop, MC Tai… - Cancer research …, 2024 - aacrjournals.org
In breast tumors, somatic mutation frequencies in TP53 and PIK3CA vary by tumor subtype
and ancestry. Emerging data suggest tumor mutation status is associated with germline …